US FDA approves Lilly’s breast cancer drug combo

The US FDA has approved Eli Lilly’s
drug combination to treat adults with ​a type of advanced
breast cancer that has spread ‌to other parts of the body, the
drugmaker ​said on Friday.

Published on September 19, 2026